Latest News about PFE
Recent news which mentions PFE
Seagen, Occidental Petroleum And 3 Stocks To Watch Heading Into Monday
February 27, 2023
From Benzinga
From MarketWatch
Pfizer In Early Talks To Buy Cancer-Focused Seagen: WSJ
February 26, 2023
From Benzinga
Pfizer/BioNTech Seek Expanded Approval For Its Updated COVID-19 Shot As Primary Series Vaccination
February 24, 2023
From Benzinga
‘Ukraine is open for business’: Western companies urged to be part of Ukrainian recovery
February 24, 2023
From MarketWatch
Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop
February 23, 2023
From Motley Fool
Wall Street's Most Accurate Analysts Say Hold These 3 Healthcare Stocks Delivering High-Dividend Yields
February 23, 2023
From Benzinga
GSK/Pfizer-Backed ViiV Healthcare's HIV Treatment At Par With Gilead's: Study Shows
February 23, 2023
From Benzinga
Cramer Says Avoid This Stock, But His Dog May Disagree: 'It Is At $10...Something's Wrong'
February 22, 2023
From Benzinga
This Recession-Proof Company Has a Best-in-Class Dividend
February 22, 2023
From Motley Fool
Want More Reliable Dividend Income? Buy This Dividend King.
February 22, 2023
From Motley Fool
Better Buy: Beam Therapeutics or Intellia Therapeutics?
February 22, 2023
From Motley Fool
My 3 Biggest Stock Market Predictions for March
February 21, 2023
From Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
February 21, 2023
From Motley Fool
3 Dividend Stocks to Buy on Sale
February 21, 2023
From Motley Fool
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later
February 18, 2023
From Motley Fool
Pfizer, Alphabet And This ETF: CNBC's 'Final Trades'
February 17, 2023
From Benzinga
10 dividend stocks with yields as high as 6.5% from a value manager with a strong track record
February 17, 2023
From MarketWatch
Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents
February 17, 2023
From Benzinga
Pfizer, Valneva Discontinue Certain Trial Sites For Phase 3 Study Of Lyme Disease Vaccine Candidate
February 17, 2023
From Benzinga
Black Professionals Working In Public Cannabis Companies To Create A More Equitable Industry
February 16, 2023
From Benzinga
Pfizer Releases Interim Update On PARP Inhibitor Combo Therapy For Prostate Cancer, Secures FDA Priority Review
February 16, 2023
Tickers
PFE
From Benzinga
Moderna’s COVID vaccine will remain free for all Americans in coup for Bernie Sanders
February 16, 2023
From MarketWatch
From MarketWatch
EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue
February 15, 2023
From Benzinga
2 High-Yielding Dividend Stocks Trading Near 52-Week Lows
February 14, 2023
From Motley Fool
Acurx is Setting a High Bar for New Treatments in C. diff
February 14, 2023
From Benzinga
Is This the Telltale Sign to Sell Novavax Stock?
February 14, 2023
From Motley Fool
These Cheap Growth Stocks Could Supercharge Your Portfolio
February 12, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.